Alternatives
Alternatives to Complera 200 mg/25 mg/300 mg tablet
1 other presentations of Emtricitabine, Rilpivirine and Tenofovir disoproxil 200 mg/25 mg/300 mg tablet
There are 1 alternatives to this medicine in the catalogue: the same active ingredient (Emtricitabine, Rilpivirine and Tenofovir disoproxil), strength (200 mg/25 mg/300 mg) and dosage form (tablet) from 1 other makers or registers. The table compares packs, storage, lead time, documents and availability.
Side by side
The first row is the medicine you came from.
| Medicine | Manufacturer | Register | Packs | Storage | Lead time | Documents | Availability |
|---|---|---|---|---|---|---|---|
| Complera 200 mg/25 mg/300 mg tabletThis pageOral | Gilead Sciences | US FDA | 30 tablets | Store at 25 °C (77 °F), excursions permitted to 15 °C–30 °C (59 °F–86 °F). | On request | — | Available on request |
| Emtricitabine, Rilpivirine and Tenofovir disoproxil 200 mg/25 mg/300 mg tabletOral | — | US FDA | 30 tablets, 30 tablets | Store at 20° to 25°C (68° to 77°F). | On request | — | Available on request |
Alternatives are listed for sourcing. Whether one medicine can replace another is the prescriber's decision, under the rules of the destination country.
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Back to Complera 200 mg/25 mg/300 mg tabletNot sure which maker to choose?
Request a quote for the medicine and we will propose the options that fit your country's import rules and timelines.